Suppr超能文献

脊柱手术中的抗凝风险。

Anticoagulation risk in spine surgery.

机构信息

Department of Neurosurgery, Vanderbilt University Medical Center, T-4224 Medical Center North, Nashville, TN 37232, USA.

出版信息

Spine (Phila Pa 1976). 2010 Apr 20;35(9 Suppl):S117-24. doi: 10.1097/BRS.0b013e3181d833d4.

Abstract

STUDY DESIGN

Systematic review.

OBJECTIVE

To determine the high-risk populations for thromboembolic events in spine surgery patients, the risk of anticoagulation in spine surgery patients by type of anticoagulation, and whether there is a safe perioperative window of nonanticoagulation for these high-risk patients.

SUMMARY OF BACKGROUND DATA

Thromboembolic complications after major spinal surgery is a significant risk for patients. Anticoagulation to reduce this risk is of concern because of the possibility of excessive bleeding or postoperative hematomas and associated neurologic deficits. There seems to be a paucity of literature on this topic.

METHODS

A systematic review of the English-language literature was undertaken for articles published between January 1990 and December 2008. Electronic databases and reference lists of key articles were searched to identify published studies examining coagulopathy in major spine surgery. Two independent reviewers assessed the strength of literature using the Grading of Recommendations Assessment, Development, and Evaluation criteria, assessing quality, quantity, and consistency of results. Disagreements were resolved by consensus.

RESULTS

A total of 93 articles were initially screened, and 29 ultimately met the predetermined inclusion criteria. The risk of thromboembolism in patients not receiving chemical prophylaxis was slightly higher in surgery to correct deformity (5.3%) and trauma patients (6.0%) than in surgery for degenerative conditions (2.3%). Fatal pulmonary embolism was rare. Bleeding complications occurred rarely with the use of anticoagulation; risk of major bleeding ranged from 0.0% to 4.3% across several types of anticoagulants. Postoperative hematoma was reported in only 10 of 2507 patients.

CONCLUSION

Venous thromboembolism is uncommon after elective spine surgery. Trauma patients are at increased risk, and chemical prophylaxis should be considered. The safe timing of the administration of anticoagulation agents is unknown.

摘要

研究设计

系统回顾。

目的

确定脊柱手术患者发生血栓栓塞事件的高危人群、不同类型抗凝药物治疗脊柱手术患者的风险,以及这些高危患者是否存在安全的围手术期非抗凝窗口。

背景资料总结

大型脊柱手术后发生血栓栓塞并发症对患者而言是一个严重的风险。由于抗凝可能导致过度出血或术后血肿及相关神经功能缺损,因此对该风险进行抗凝治疗存在顾虑。关于这个主题的文献似乎很少。

方法

对 1990 年 1 月至 2008 年 12 月期间发表的英文文献进行了系统回顾。电子数据库和关键文章的参考文献列表被检索以识别发表的研究,这些研究检查了大型脊柱手术中的凝血功能障碍。两名独立的审查员使用推荐评估、制定和评估标准(Grading of Recommendations Assessment, Development, and Evaluation criteria)评估文献的强度,评估质量、数量和结果的一致性。通过共识解决分歧。

结果

最初筛选了 93 篇文章,最终有 29 篇符合预定的纳入标准。未接受化学预防的患者发生血栓栓塞的风险在接受矫形手术(5.3%)和创伤患者(6.0%)中略高于退行性疾病手术(2.3%)。致命性肺栓塞罕见。抗凝治疗很少出现出血并发症;几种类型的抗凝药物的大出血风险范围从 0.0%到 4.3%。仅在 2507 例患者中有 10 例报告了术后血肿。

结论

择期脊柱手术后静脉血栓栓塞并不常见。创伤患者风险增加,应考虑使用化学预防。抗凝药物给药的安全时机尚不清楚。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验